These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19394667)

  • 1. Interindividual differences in o,p'-DDD enantiomer kinetics examined in Göttingen minipigs.
    Cantillana T; Lindström V; Eriksson L; Brandt I; Bergman A
    Chemosphere; 2009 Jun; 76(2):167-72. PubMed ID: 19394667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs.
    Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells.
    Asp V; Cantillana T; Bergman A; Brandt I
    Xenobiotica; 2010 Mar; 40(3):177-83. PubMed ID: 20044879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two multidimensional chromatographic methods for enantiomeric analysis of o,p'-DDT and o,p'-DDD in contaminated soil and air in a malaria area of South Africa.
    Naudé Y; Rohwer ER
    Anal Chim Acta; 2012 Jun; 730():120-6. PubMed ID: 22632053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
    Watson AD; Rijnberk A; Moolenaar AJ
    Res Vet Sci; 1987 Sep; 43(2):160-5. PubMed ID: 3685628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 1-(0-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p'-DDD) in rats.
    Reif VD; Sinsheimer JE
    Drug Metab Dispos; 1975; 3(1):15-25. PubMed ID: 234830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
    Kasperlik-Zaluska AA; Cichocki A
    J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient.
    Dickerman Z; Kaufman H; Laron Z
    Isr J Med Sci; 1979 May; 15(5):455-9. PubMed ID: 447515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
    Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
    Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells.
    Hermansson V; Asp V; Bergman A; Bergström U; Brandt I
    Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic activity of dicofol with the human estrogen receptor: Isomer- and enantiomer-specific implications.
    Hoekstra PF; Burnison BK; Garrison AW; Neheli T; Muir DC
    Chemosphere; 2006 Jun; 64(1):174-7. PubMed ID: 16337670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals.
    Moore RN; Penney DP; Averill KT
    Anat Rec; 1980 Sep; 198(1):113-24. PubMed ID: 7457928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric ratios as an indicator of exposure processes for persistent pollutants in human placentas.
    Shen H; Virtanen HE; Main KM; Kaleva M; Andersson AM; Skakkebaek NE; Toppari J; Schramm KW
    Chemosphere; 2006 Jan; 62(3):390-5. PubMed ID: 16005046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective induction of cytotoxicity by o,p'-DDD in PC12 cells: implications of chirality in risk assessment of POPs metabolites.
    Wang C; Li Z; Zhang Q; Zhao M; Liu W
    Environ Sci Technol; 2013 Apr; 47(8):3909-17. PubMed ID: 23485034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aromatase inhibitor and tamoxifen decrease plasma levels of o,p'-DDT and its metabolites in Nile tilapia (Oreochromis niloticus).
    Leaños-Castañeda O; Gold-Bouchot G; Van Der Kraak G; Lister A; Ceja-Moreno V; Simá-Alvarez R
    Mar Environ Res; 2004; 58(2-5):337-42. PubMed ID: 15178051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of chiral ratio of o,p-DDT and o,p-DDD pesticides on polysaccharides chiral stationary phases by HPLC under reversed-phase mode.
    Ali I; Aboul-Enein HY
    Environ Toxicol; 2002; 17(4):329-33. PubMed ID: 12203953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of recurrent adrenocortical carcinoma, with observations on long-term o,p'-DDD therapy and complications.
    van Aalderen W; van Seters AP; Backer ET; Chang PC; van Krieken JH; Moolenaar AJ
    Neth J Med; 1992 Oct; 41(3-4):161-70. PubMed ID: 1470288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses.
    Benecke R; Keller E; Vetter B; de Zeeuw RA
    Eur J Clin Pharmacol; 1991; 41(3):259-61. PubMed ID: 1748144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of O,N'=dichlorodiphenyldichloroethane and pertan in vitro on glutathione reductase activity in the adrenals of dogs and guinea pigs].
    Komissarenko VP; Chelnakova IS; Mikosha AS
    Biull Eksp Biol Med; 1978 Feb; 85(2):159-61. PubMed ID: 630087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolism of o,p'-DDD (mitotane) in human and animals. Actual notions and practical deductions (author's transl)].
    Touitou Y; Bogdan A; Legrand JC; Desgrez P
    Ann Endocrinol (Paris); 1977; 38(1):13-25. PubMed ID: 324349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.